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Introduction {#sec001}
============

Chronic aerobic exercise acutely improves health and lowers the long-term probability of cardiovascular disease, diabetes, obesity, cancer (colon and breast), osteoporosis, hypertension and lipid abnormalities \[[@pone.0235792.ref001]--[@pone.0235792.ref006]\]. Moreover, chronic exercise has been shown to enhance glucose homeostasis, insulin sensitivity, and body composition \[[@pone.0235792.ref007]--[@pone.0235792.ref009]\], while lowering anxiety, depression and stress \[[@pone.0235792.ref010]--[@pone.0235792.ref012]\]. Despite these diverse benefits, only 53% of the United States population exercise regularly \[[@pone.0235792.ref013]\]. This lack of exercise may result from lifestyle preferences, job requirements, or immobility associated with hospitalization or chronic injury. Partially because of this inactivity, 40% of the population is obese and suffers from diabetes (15%) and/or cardiovascular disease (12.1%) \[[@pone.0235792.ref013]\]. Therefore, alternative strategies that promote outcomes typically linked to exercise are required.

One possible strategy is to employ VR technology to serve as an alternative treatment in combination with, or as a replacement for, bona fide physical exercise. VR is an emerging technology that creates an interactive virtual environment, incorporating auditory and visual simulations, that provide an immersive experience \[[@pone.0235792.ref014]\]. The perception of reality is achieved by the use of head-mounted displays and touch-sensitive gloves or controllers \[[@pone.0235792.ref015]\]. Movements of the head and body are tracked and correspond to the virtual movement, which allows the user to explore and be immersed in the virtual environment \[[@pone.0235792.ref016]\]. Immersing participants in a virtual environment leads to a sensation of agency, in which participants feel a sense of identification and control over the avatar \[[@pone.0235792.ref017]\]. VR technology has already been used in the treatment of psychiatric disorders, pain, physical disabilities and child behavior \[[@pone.0235792.ref015], [@pone.0235792.ref018]--[@pone.0235792.ref020]\], and to augment procedures associated with plastic surgery and dentistry \[[@pone.0235792.ref021], [@pone.0235792.ref022]\].

Chronic application of simulated exercise can induce beneficial outcomes in stationary *Drosophila* \[[@pone.0235792.ref023]\]. In flies, octopamine, the invertebrate equivalent of norepinephrine, is critical for exercise adaptation. Intermittent activation of octopaminergic neurons through genetic means is sufficient to drive beneficial exercise adaptions in stationary *Drosophila* \[[@pone.0235792.ref023]\] that are indistinguishable from those seen in flies that actually performed daily exercise.

The findings in *Drosophila*, coupled with the fact that epinephrine and norepinephrine increase during exercise in humans, and the fact that VR has been shown to be capable of increasing HR in stationary users \[[@pone.0235792.ref024], [@pone.0235792.ref025]\], led us to propose that intermittent stimulation of adrenergic signaling might have therapeutic benefit in humans with a sedentary lifestyle \[[@pone.0235792.ref026]\].

As a first step toward this goal, we hypothesized that simulated exercise may lead to increases in sympatho-vagal balance and decreases in parasympathetic nervous system activity that are ultimately coupled to increased norepinephrine release and heart rate. To test this hypothesis, we measured heart rate variability during virtual exercise and norepinephrine levels before and immediately after virtual exercise, and compared them to the same parameters measured during high or moderate-intensity exercise. The goal of this study was to establish the practicality of utilizing VR as a method of intermittent sympathetic stimulation, as a precursor to further studies examining the effects of such treatment over a longer-term on healthy participants or patients with chronic disease or disability.

Methods {#sec002}
=======

Participants {#sec003}
------------

Twenty-four healthy individuals ([S1](#pone.0235792.s002){ref-type="supplementary-material"} and [S2](#pone.0235792.s003){ref-type="supplementary-material"} Tables) were recruited by advertising on Wayne State University's website and through departmental listservs as a convenience sampling strategy of healthy adults able to tolerate VR. Following recruitment, participants attended a pre-screening interview to review the study protocol and to determine if the participants met the inclusion/exclusion criteria. The inclusion criteria included an absence of cardiovascular disease and diabetes, the absence of medications that could affect the response to exercise, such as beta-blockers or selective serotonin reuptake inhibitors (SSRI), and the absence of anxiety or nausea if participants had previous experience with VR.

Ethics {#sec004}
------

The Wayne State University Institutional Review Board approved the study and all participants provided written consent before participating in the study.

Study protocol {#sec005}
--------------

The twenty-four participants were allocated to an experimental group or a no prior exposure control group ([Fig 1](#pone.0235792.g001){ref-type="fig"}). The experimental group was comprised of 17 participants (11 men and 6 women) who completed 3 sessions with varying stimuli. Each participant performed the 3 sessions in the same order and each session was separated by a week. The no prior exposure group was comprised of 7 participants (4 men and 3 women) who completed a single VR-simulated exercise session. Participants were asked to abstain from caffeinated beverages and nicotine for at least 2 hours before a session. For the initial session, each participant in the experimental group performed 15 minutes of exercise on a recumbent bicycle (EX--[Fig 1](#pone.0235792.g001){ref-type="fig"}). The participants pedaled at a frequency of 72--94 RPM that resulted in a speed of 9--10 MPH with added resistance set to mimic the exercise intensity of the pre-set HOLOFIT software (see *Equipment* for description of software). During the second session (EX + VR---[Fig 1](#pone.0235792.g001){ref-type="fig"}), each participant performed 15 minutes of exercise while wearing a VR headset that provided visual and auditory sensory inputs. Speed and movement of the avatar in the virtual reality environment was controlled by the participant using a recumbent bicycle. In the VR headset, when participants looked down they could see the avatar's legs matching the speed and the movement of their own legs on the recumbent bicycle. Resistance and speed of cycling was identical to the EX session.

![Experimental setup.\
A, Step-wise description of the exercise protocol; B, Details of the experimental and the no prior exposure group.](pone.0235792.g001){#pone.0235792.g001}

Throughout the third session, the participants wore the VR headset and instead of performing physical exercise for 15 minutes, the participants controlled the VR environment with a keyboard (VR---[Fig 1](#pone.0235792.g001){ref-type="fig"}). Consequently, participants were able to control the virtual environment and receive visual input consistent with exercise, but did not perform aerobic exercise. The no prior exposure group also completed 15 minutes of virtual exercise. However, in this case, the session was completed without prior exposure to VR or the recumbent bicycle (VR NPE--[Fig 1](#pone.0235792.g001){ref-type="fig"}). The no prior exposure group served as a control for the effects of learned expectations or familiarity with the environment.

For all groups, HR, blood pressure and plasma norepinephrine levels were measured immediately before and after the exercise. HR was also monitored throughout the exercise period via electrocardiogram. Exercise intensity during EX was determined by dividing the average HR over the last five minutes of exercise by the maximum HR calculated using the equation:191.5 --(0.007 × age^2^) = Maximum HR \[[@pone.0235792.ref027]\]. Participants were separated into high-intensity or moderate-intensity groups on a *post-hoc* basis, according to their measured HR during the initial cycling session, using a cutoff of 70% maximum HR.

Equipment {#sec006}
---------

A VR headset (HTV Vive, Taiwan) along with a gaming mini-PC (Zotac ZBOX MAGNUS EN1070K, Dongguan City, China) was used. The virtual environment was created using HOLOFIT commercial software (HOLODIA, Zurich, Switzerland) and provided participants with visual stimuli of cycling through a desert canyon environment. The software was altered so that a keyboard or a recumbent bicycle could be used to control the virtual environment. The keyboard was used because of the available compatibility with HOLOFIT software and the requirement of minimum movement of participants. A recumbent Lifecycle bike (Life Fitness activate series OSR-XX, Illinois, USA) with cSAFE protocol was used since it was compatible with the HOLOFIT commercial software.

Data acquisition and analysis {#sec007}
-----------------------------

Two ml of venous blood was obtained from the antecubital vein before and after each exercise session. The sampled blood was centrifuged and serum was aliquoted and stored at -80°C for subsequent analyses. Serum concentrations of norepinephrine levels were assessed in duplicates using an enzyme-linked immunosorbent assay (Abnova, Taiwan). Briefly, following sample preparation, extraction and acylation, an enzyme solution and serum samples were added into wells of a microplate plate. Samples were incubated for 30 min before adding antiserum into all wells and incubating for 2 hours. The plate was then washed, an enzyme conjugate was added into all wells, and samples were incubated for 30 min. The plate was washed again with wash buffer, substrate was added into all wells and incubated for approximately 25 min. The stop solution was added to the plate and absorbance was read within 10 min using a microplate reader set to 450 nm.

Blood pressure was measured before and after each exercise session, using a blood pressure monitor (Omron 5 Series, Omron, Lake Forest, IL). Intra-correlation coefficients within each group (Groups HI and MI are described below) were greater than or equal to 0.86 for systolic and 0.75 for diastolic, indicating a high degree of reproducibility between baseline measurements for each individual. In addition, an electrocardiogram was recorded throughout (i.e. 15 minutes) the physical and virtual exercise sessions using a two-lead configuration. Data acquisition was performed using LabChart Software V8 (ADInstruments, Sydney, Australia).

Average measures of blood pressure, norepinephrine and HR, are shown for each participant before and after each exercise session in [S1 Table](#pone.0235792.s002){ref-type="supplementary-material"}, with individual raw data for the same measures shown in S2 Table. These parameters were not significantly different between men and women. Thus, data were combined for analysis. Although there was substantial variation in baseline norepinephrine measurements ([S1 Table](#pone.0235792.s002){ref-type="supplementary-material"}), we found no correlation between baseline norepinephrine and the degree of change in norepinephrine after exercise ([S1 Fig](#pone.0235792.s001){ref-type="supplementary-material"}), except in the VR only group, where a low baseline norepinephrine significantly correlated with a high change in norepinephrine (VR: P = 0.001, r = 0.74, CI = -0.92 to -0.30).

Based on the increase in HR (i.e., % of maximum HR) during the initial exercise session (EX), participants were divided into two distinct groups that exercised at high (\< 70% maximum HR) or moderate intensity (\> 70% maximum HR) (HI and MI, respectively). This cutoff was chosen because it best described the data from this set of participants and is similar to the target HRs used by the American Heart Association to delineate high and moderate intensity \[[@pone.0235792.ref028]\]. The HI group was comprised of 6 participants, while the MI group was comprised of 11 participants.

Spectral analysis of heart rate variability was determined from the electrocardiogram recorded during the last 5 minutes of each exercise session as previously described \[[@pone.0235792.ref029]\]. The last 5 minutes in each exercise session were chosen because the participants were expected to undergo maximum exertion during that time. Spectral components for heart rate variability were measured in absolute units (ms^2^/Hz). Power in the low-frequency range (LF R-R: 0.04 to 0.15 Hz), and high-frequency range (HF R-R: 0.15 to 0.40 Hz) was determined and the LF/HF ratio was calculated. Modifications in the high-frequency range was considered to represent changes in parasympathetic nervous system activity while the LF/HF ratio was considered to reflect sympathovagal balance \[[@pone.0235792.ref030]\]. The heart rate variability data was ln transformed before statistical analysis was completed because the data was not normally distributed. HF and LF/HF were calculated using the data collected during the initial exercise session (EX), the virtual exercise session (VR) and the virtual exercise session with no prior exposure (VR NPE).

Statistical analysis {#sec008}
--------------------

Absolute measures of blood pressure, norepinephrine and HR, before and after exercise, were compared across sessions. Results were analyzed by a two-way repeated measures ANOVA with a Tukey post-hoc test. The factors in the design were time (before vs. after exercise) and session (EX vs. EX+VR vs. VR). In addition, the data collected before and after VR were compared between the experimental group and no prior exposure group (i.e. VR NPE), using a two-way ANOVA followed by a Tukey post-hoc test. The factors in the design were time point (before vs. after exercise) and group (VR vs. VR NPE). For all comparisons, p-values of 0.05 or lower were considered significant. Statistical analysis was performed with GraphPad Prism 7 (Graph Pad, La Jolla, CA), except for intra-class correlation (ICC) and effect size (ES) analysis, which was performed with SPSS v26.0 (IBM Corporation, Armonk, NY).

A Pearson correlation was used to determine the association between % maximum HR achieved during the last five minutes of exercise in the initial session (EX) and the difference in HR and heart rate variability during EX and VR (e.g. HR during the last 5 minutes of EX--HR during the last 5 minutes of VR), or norepinephrine immediately after EX and VR.

Lastly, an unpaired t-test was used to compare HR and heart rate variability measures during the last five minutes of EX and VR between groups group, or norepinephrine levels immediately following EX or VR, in the HI and MI groups.

Results {#sec009}
=======

Blood pressure, heart rate and norepinephrine {#sec010}
---------------------------------------------

Systolic ([Fig 2A](#pone.0235792.g002){ref-type="fig"}) and diastolic ([Fig 2B](#pone.0235792.g002){ref-type="fig"}) blood pressure was not significantly different immediately after any treatment. HR immediately following EX (P \< 0.0001, ES = 1.9, CI = -40.21 to 16.03) and EX + VR (P \< 0.0001, ES = 1.9, CI = -37.76 to -22.09) was significantly elevated compared to baseline but this was not the case following VR. Norepinephrine measured immediately after exercise was not greater than baseline for any pairwise comparison.

![Parameters measured before and after the exercise sessions.\
A, Systolic blood pressure; B, Diastolic blood pressure; C, HR and D, Norepinephrine. The main effect of the treatment was significant across all groups for systolic blood pressure, HR and norepinephrine, but there were no significant differences in pairwise comparisons for individual groups. HR was significantly increased in the exercised group and in EX+VR group. Abbreviations: EX, Physical exercise group; EX+VR, Physical exercise group with a VR headset on; VR, Virtual exercise group; VR NPE, Virtual exercise group with no prior exposure to physical and virtual exercise.](pone.0235792.g002){#pone.0235792.g002}

Heart rate variability {#sec011}
----------------------

To compare the acute effects of physical and VR exercise, we analyzed electrocardiogram traces from the last five minutes of EX and VR to determine HR and heart rate variability for each participant. We then plotted the difference in HR during EX and VR for each participant. In most participants, HR during EX was higher than HR during VR ([Fig 3A](#pone.0235792.g003){ref-type="fig"}).

![Correlations between % maximum heart rate and other parameters.\
Percent of maximum HR measured during exercise is plotted against differences in HR (A), norepinephrine (B), parasympathetic nervous system activity (ln HF) (C) and sympathovagal balance (ln LF/HF) (D) measured from the last 5 minutes of actual exercise (EX) and virtual exercise (VR). Measurements in A, C, and D are taken during exercise, while measurements in B were taken immediately after exercise. Note that the difference in HR, norepinephrine and sympathovagal balance measured during EX compared to VR was greater in those participants that exercised at a higher intensity during EX, as determined by the percentage of maximum HR. Likewise, a greater decrease in parasympathetic activity during EX compared to VR was evident in those participants that exercised at a higher intensity. Lastly, note that the black arrows in each graph represent the point on the predicted line where the response to actual and virtual exercise would be similar. These points indicate that responses during VR exercise are capable of inducing physiological responses similar to that induced during actual mild to moderate exercise (40% - 60% of maximum HR). 95% confidence intervals are shown on each scatterplot.](pone.0235792.g003){#pone.0235792.g003}

The intensity of physical exercise (as indicated by the % of maximum HR achieved during the last 5 minutes of exercise during EX) predicted the difference in HR during EX and VR for an individual participant ([Fig 3A](#pone.0235792.g003){ref-type="fig"}). Specifically, participants that engaged in high-intensity physical exercise during EX experienced a greater increase in HR ([Fig 3A](#pone.0235792.g003){ref-type="fig"}), norepinephrine ([Fig 3B](#pone.0235792.g003){ref-type="fig"}) and sympathovagal balance ([Fig 3D](#pone.0235792.g003){ref-type="fig"}) compared to VR exercise. In contrast, a greater decrease in parasympathetic nervous system activity (lnHF) was evident during EX compared to VR in those participants engaged in high intensity exercise ([Fig 3C](#pone.0235792.g003){ref-type="fig"}). A similar physiological response during EX and VR was evident in those participants that engaged in moderate-intensity exercise during EX. The point on the correlation line where the response to actual and virtual exercise would be identical is marked with a black arrow ([Fig 3](#pone.0235792.g003){ref-type="fig"}).

Those participants whose HR was greater than 70% of maximum HR during EX were classified as high intensity (HI) exercisers while the participants whose HR was less than 70% of maximum were considered to have engaged in moderate intensity (MI) exercise. This grouping resulted in 6 participants who engaged in high-intensity exercise (80.9 ± 2.8% maximum HR) and 10 that engaged in moderate-intensity exercise (60.0 ± 2.7% maximum HR). Data from one participant was not available because of technical issues.

HR during EX and VR was significantly higher in the HI compared to the MI group (EX: P \< 0.0002, ES = 2.7, CI = 22.4--55.8 & VR: P \< 0.04, ES = 1.1, CI = 0.9--23.0). In addition, the HR difference between EX and VR was greater in magnitude in the HI compared to the MI group (P \< 0.02, ES = 1.4, CI = 5.9--48.7) ([Fig 4A](#pone.0235792.g004){ref-type="fig"}). Post-exercise norepinephrine was greater after EX in the HI compared to the MI group (p \< 0.02, ES = 1.3, CI = 52.7--520.3). However, post-exercise norepinephrine following VR was similar in the HI and MI group (p = 0.36, ES = 0.5, CI = - 84.4--215.7). Parasympathetic nervous system activity was reduced during EX in the HI compared to the MI group (P \< 0.03, ES = 1.0, CI = - 4.1--0.09) ([Fig 4C](#pone.0235792.g004){ref-type="fig"}). In contrast, parasympathetic nervous system activity was similar during VR in the HI and MI group (p = 0.24, ES = 0.7, CI = - 0.5--1.9). Sympathovagal balance was similar during EX in the HI and MI group (p = 0.73, ES = 0.2, CI = - 1.0--1.4). In contrast, sympathovagal balance was reduced during EX in the HI compared to the MI group (P \< 0.03, ES = 1.2, CI = - 1.7 --- 0.1) ([Fig 4D](#pone.0235792.g004){ref-type="fig"}).

![Parameters measured for the HI and MI exercise groups during EX and VR sessions.\
A, HR measured during the last five minutes of exercise; B, Norepinephrine measured after the exercise sessions; C, Parasympathetic nervous system activity (ln HF) measured during the last five minutes of exercise; D, Sympathovagal balance (ln LF/HF) measured during the last five minutes of exercise. Note that sympathovagal balance (ln LF/HF) was greater during VR in the MI compared to the HI group and that the response in the MI group was similar to the response measured from this group during EX. Abbreviations: EX---Physical exercise; VR---Virtual exercise; HI---High intensity; MI---Moderate intensity. \*---significantly different from MI.](pone.0235792.g004){#pone.0235792.g004}

Discussion {#sec012}
==========

VR has found multiple effective therapeutic uses in recent years, to increase exercise motivation \[[@pone.0235792.ref031]\], and to stimulate HR in stationary users \[[@pone.0235792.ref024], [@pone.0235792.ref025]\]. Its use to encourage patients to complete therapeutic recovery regimens, sometimes called exergaming, is particularly well-developed \[[@pone.0235792.ref032], [@pone.0235792.ref033]\]. Movement based VR exer-gaming is also becoming a popular exercise modality in healthy adults, and has been shown to increase HR and metabolic rate (i.e. oxygen consumption) from \'moderate\' to \'vigorous\' levels depending on the VR experience \[[@pone.0235792.ref034]\]. However, the use of VR to induce a physiological response that mimics exercise is not as well studied as its role in promoting exercise motivation. This study set out to address the question of whether VR exercise could increase HR and norepinephrine release to a comparable extent as actual cycling for the same duration.

Although others have reported increased HR during VR when participants caused an avatar to move \[[@pone.0235792.ref024]\], we did not observe consistent significant effects of VR on HR across all participants, although there was substantial individual variance. During the course of measuring the baseline exercise response, we noticed that participants could easily be divided into two groups based on their HR response to actual cycling (i.e. HI and MI groups). This division likely reflects differences in baseline fitness in our participants, which is consistent with results from our observations of the participants. Even though the rate and resistance of the bicycle were identical between participants, some participants clearly found the set point of exercise more difficult than others.

Virtual exercise was not able to replicate the physiological responses measured during HI exercise. However, among participants experiencing MI exercise conditions, norepinephrine levels and measures of heart rate variability were not statistically different from those measured during VR. This finding suggests that virtual exercise has the potential to successfully replicate moderate, exercise-induced changes to sympathovagal balance, but is unlikely to be effective at replicating intense endurance exercise.

There were certain limitations to this study. The study participants had a wide variety of physical fitness, including some, presumably at a high baseline fitness level, that showed minimal increases in HR and norepinephrine during both actual and virtual exercises, lowering the overall average responses. Other participants had unusually high baseline norepinephrine levels, for unknown reasons, which tended to blunt their exercise-induced change in norepinephrine levels. Participants were asked to refrain from stimulants for at least two hours before coming to the lab, and this may not have been sufficient to prevent effects of caffeine or nicotine. A few participants were apprehensive about the blood draw, which might have affected their HR and norepinephrine measurements. Although we made sure to take the post-exercise blood draws immediately after the exercise sessions, even a slight delay could have affected the change in norepinephrine levels compared to the baseline, since the half-life of norepinephrine in blood is 2--2.5 minutes \[[@pone.0235792.ref035]\]. The variation in baseline HR amongst participants was also high, for unknown reasons.

In summary, these results offer an early indication that virtual exercise may be able to mimic some of the effects on the autonomic nervous system associated with moderate exercise, though not highly strenuous endurance exercise. This possibility merits further investigation, as moderate exercise has profound salutary effects on stationary patients. Mild/Moderate exercise has been shown to lower blood pressure \[[@pone.0235792.ref036], [@pone.0235792.ref037]\], lower total serum cholesterol \[[@pone.0235792.ref038]\], maintain a healthy LDL/HDL ratio \[[@pone.0235792.ref038]\], improve body composition \[[@pone.0235792.ref038]\], protect myocardial function \[[@pone.0235792.ref039]\], prevent glucose intolerance \[[@pone.0235792.ref040]\], improve autonomic nervous system \[[@pone.0235792.ref041]\] and increase insulin sensitivity \[[@pone.0235792.ref042]\]. Patients with extended debilitating illnesses or injuries that lack access to daily exercise often suffer reduced metabolic fitness, and exposure to the benefits of moderate exercise could preserve such patients against compounding factors caused by sedentary periods. Given the low cost and lack of side effects of virtual exercise treatment, it has the potential, once better understood, to become an effective treatment tool for a wide cross-section of sedentary patients. This study provides proof-of-principle for more extensive and detailed future studies to further develop this potential treatment.

Supporting information {#sec013}
======================

###### Correlations between Δ norepinephrine and baseline norepinephrine.

A, Correlation in cycling group; B, Correlation for group that cycled using the VR environment; C, Correlation for group that experienced virtual exercise without cycling; D, Correlation for group that experienced vitual exercise without prior exposure.

(TIF)

###### 

Click here for additional data file.

###### Participants' characteristics, hemodynamic variables and norepinephrine levels pre- and post-exercise as mean +/- SD.

(DOCX)

###### 

Click here for additional data file.

###### Participants' characteristics, hemodynamic variables and norepinephrine levels pre- and post-exercise.

(DOCX)

###### 

Click here for additional data file.
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Line 33: Make it clear here that the \"simulation\" session included no actual exercise: \"\...to simulate exercise (without cycling exercise)\...\"

Line: 34: Abbreviate \'heart rate\' as \"HR\" starting here, and throughout the paper.

Line 36: \"find\" should be \"found\".

Introduction:

Line 48: Please specify this is \"Chronic aerobic exercise\" in the first sentence and combine the 1st and 2nd paragraphs .

Line 53: Make it clear that these data are from the US: \"\...of the population of the United States (US) exercises regularly\...\".

Line 58: Again, abbreviate \'virtual reality\' as \"VR\" starting here, and throughout the paper.

Line 62: Specify that it is either a \"head-mounted display or wall projector\".

Line 86: Include this group at the end of the intro: \"\... with chronic disease or disability.\"

Methods:

Table 1: Please report this table with individual data as a supplement table. The data for each participant is not necessary here. Instead please re-create this table with \'mean +/- SD in each group, session, and variable pre- and post- exercise (be sure to identify which session was which, and identify abbreviations in the heading (HI, MI, NPE).

Line 111: I\'m note sure that 2 hours without stimulants is long enough to clear from a human system. Please state why 2 hours was chosen as a cutoff for abstaining from caffeine and nicotine, and not longer. Also, where any other controls taking into account? Did the participants refrain from exercise prior to the trials? This could have affected baseline norepinephrine levels.

Line 136: Please cite the source of this MaxHR equation.

Line 154: Briefly describe your ELISA protocol (or cite source of similar protocol from your lab).

Line 182: Space out \"minutesin\".

Line 209: State your alpha-level for significance and any statistical analysis software used.

Discussion:

Line 284: In the discussion, I think it\'s also important to note that VR exer-gaming is also being used by healthy people for exercise, and has been shown to increase metabolic rate (measured by VO2 consumption) and HR. Metabolic rate would be a good measure for future studies on virtual exercise\... Consider including a sentence like this:

\"\...particularly well-developed \[32, 33\]. Movement based VR exer-gaming is also becoming a popular exercise modality in health adults, and has been shown in increase HR and metabolic rate (oxygen consumption, VO2) from \'moderate\' to \'vigorous\' levels depending on the VR experience (Cite Gomez, 2018). However, the use of VR to induce\...\". Please cite Gomez 2018 here (<https://pubmed.ncbi.nlm.nih.gov/30325233/>).

References:

Please ensure that references are correctly formatted (some journal titles are capitalized, others are not).
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While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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We have attached a full pint by point letter responding to each reviewer comment. The major concern about HRV interpretation has been addressed by modifying our description of results to focus on sympathovagal balance rather than sympathetic activity per se. This change is reflected in the revised manuscript title. See letter for other responses. We thank the reviewers for their thoughtful comments,
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Dear Dr. Wessells,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 24 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <plosone@plos.org>. When you\'re ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled \'Manuscript\'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

We look forward to receiving your revised manuscript.

Kind regards,

Huimin Yan

Academic Editor

PLOS ONE
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Reviewer \#1: This revised manuscript is a significant improvement. I do have a few suggestions that I think will further improve this manuscript.

-Page 4, line 78. The authors simply state, \'\...modifications in autonomic control\...\' as part of their hypothesis. This is pretty non-descriptive and doesn\'t really help the reader. I\'d suggest being specific here.

-Page 12, line 250. The authors state \'(HF)\' but don\'t they really mean (lnHF)?

-Page 12, line 266. Post exercise or post-exercise? The authors keep changing. I\'d suggest double checking document for consistency.

Reviewer \#2: All of my previous comments/suggestions have been addressed. I feel this paper has been made stronger based on the edits made regarding my, and the other reviewers\', comments.

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Response To Reviewers

We thank the reviewers for their suggestions and criticisms which have substantially improved the manuscript. The reviewer comments are listed below with our responses.

Page 4, line 78. The authors simply state, \'\...modifications in autonomic control\...\' as part of their hypothesis. This is pretty non-descriptive and doesn\'t really help the reader. I\'d suggest being specific here.

We changed the sentence to read as follows:

As a first step toward this goal, we hypothesized that simulated exercise may lead to increases in sympatho-vagal balance and decreases in parasympathetic nervous system activity that are ultimately coupled to increased norepinephrine release and heart rate.

Page 12, line 250. The authors state \'(HF)\' but don\'t they really mean (lnHF)?

We have changed this to say (lnHF).

Page 12, line 266. Post exercise or post-exercise? The authors keep changing. I\'d suggest double checking document for consistency.

We have double-checked and the manuscript now consistently uses hyphens after each use of "post".
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Dear Dr. Wessells,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.
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Huimin Yan

Academic Editor
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The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.
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PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.
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